Tempest Therapeutics Inc. logo

Tempest Therapeutics Inc.

Tempest Therapeutics, spun out of Versant Ventures drug-discovery labs, is developing unique portfolio of small molecule therapeutics for novel and key emerging targets in immuno-oncology.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.tempesttx.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
One Sansome Street Suite 3690, CA 94104
San Francisco
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/tempesttx” connections=”true” suffix=””]

In Mar 2018, Tempest Therapeutics raised $70 Mn in Series B financing led by founding investor Versant Ventures and by F-Prime Capital, Quan Capital, Lilly Asia Ventures, Foresite Capital and Eight Roads Ventures.